SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-11-000357
Filing Date
2011-04-21
Accepted
2011-04-21 12:48:38
Documents
9
Period of Report
2011-04-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR APRIL 21, 2011 nymox6k110421.htm 6-K 4661
2 NOTICE OF ANNUAL GENERAL MEETING AND MANAGEMENT PROXY CIRCULAR exhibit99-1.htm EX-99.1 210776
3 FORM OF PROXY exhibit99-2.htm EX-99.2 21213
4 nymox.jpg GRAPHIC 5677
5 proxyx1x1.jpg GRAPHIC 1700
6 proxyx1x2.jpg GRAPHIC 4155
7 proxyx1x3.jpg GRAPHIC 4303
8 proxyx1x4.jpg GRAPHIC 4487
9 exhibit99-1x7x1.jpg GRAPHIC 69146
  Complete submission text file 0001176256-11-000357.txt   361684
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 11772857
SIC: 2835 In Vitro & In Vivo Diagnostic Substances